Anti-CD19 Allo-CAR-T Cells for Relapsed B Cell Malignancies After HSCT

NCT04516551 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Relapsed Adult ALL
B Cell Leukemia

Interventions

BIOLOGICAL: anti-CD19 allo-CAR-T cells

Sponsor

Xinqiao Hospital of Chongqing

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]